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ABSTRACT
Background Current multimodal approaches for the
management of non-speciﬁc patellofemoral pain are not
optimal, however, targeted intervention for subgroups
could improve patient outcomes. This study explores
whether subgrouping of non-speciﬁc patellofemoral pain
patients, using a series of low cost simple clinical tests,
is possible.
Method The exclusivity and clinical importance of
potential subgroups was assessed by applying à priori
test thresholds (1 SD) from seven clinical tests in a
sample of adult patients with non-speciﬁc patellofemoral
pain. Hierarchical clustering and latent proﬁle analysis,
were used to gain additional insights into subgroups
using data from the same clinical tests.
Results 130 participants were recruited, 127 had
complete data: 84 (66%) female, mean age 26 years
(SD 5.7) and mean body mass index 25.4 (SD 5.83),
median (IQR) time between onset of pain and
assessment was 24 (7–60) months. Potential subgroups
deﬁned by the à priori test thresholds were not mutually
exclusive and patients frequently fell into multiple
subgroups. Using hierarchical clustering and latent
proﬁle analysis three subgroups were identiﬁed using 6
of the 7 clinical tests. These subgroups were given the
following nomenclature: (1) ‘strong’, (2) ‘weak and
tighter’ and (3) ‘weak and pronated foot’.
Conclusions We conclude that three subgroups of
patellofemoral patients may exist based on the results of
six clinical tests which are feasible to perform in routine
clinical practice. Further research is needed to validate
these ﬁndings in other data sets and, if supported by
external validation, to see if targeted interventions for
these subgroups improve patient outcomes.
BACKGROUND
Non-speciﬁc patellofemoral pain (PFP) is a muscu-
loskeletal disorder of the knee joint that causes sig-
niﬁcant pain and dysfunction around the patella
leading to limitations in physical activities.1 The
condition is not self-limiting, 90% of patients with
PFP still have symptoms 4 years after diagnosis,2 3
and only 6% are symptom free at 16 years
follow-up.4
PFP may be a risk factor for developing patello-
femoral osteoarthritis (OA).5 6 PFP has recently
emerged as the third highest ranked topic out of
185 in the Chartered Society of Physiotherapy
(UK) Musculoskeletal Research Priority Project.7
Expert consensus statements published following
three International Patellofemoral Pain Research
Retreats (IPFPRR) propose biomechanical risk
factors for developing PFP described by anatomical
location relative to the knee. These factors are:
Proximal—upper femur, hip and trunk; Local—in
and around the patella and the patellofemoral
joint; Distal—lower leg foot and ankle.8–10 These
risk factors may guide in developing clinical
subgroups.
Subgrouping approaches have proved fruitful to
optimise management in other musculoskeletal
conditions such as low back pain, in which psycho-
social characteristics have also been incorporated
into subgroup criteria.11 12 Previous authors have
investigated subgroups within the PFP population
using specialised high cost equipment not routinely
seen in clinic for example, radiographic examin-
ation and scintigraphy,13 dynamic MRI14 15 and six
camera three-dimensional motion analysis
systems.16 The translation of these results into
routine practice in physiotherapy clinics is therefore
likely to be limited. With the exception of Dierks
et al16 the focus of these studies has tended to be
on local biomechanical factors, rather than adopt-
ing an holistic approach that also incorporates
proximal and distal factors.
Recently Selhorst et al17 reported on a pilot
study of 21 paediatric patients with PFP, mean age
14 years, where they deﬁned a new PFP classiﬁca-
tion algorithm that contains four subgroups; ele-
vated fear avoidance, decreased muscle ﬂexibility,
functional malalignment, decreased muscle
strength. Unfortunately they provided no details
are as to how the four groups were derived. Keays
et al18 also described four clinical PFP subgroups;
hypermobility, hypomobility, faulty movement
pattern, osteoarthritis. Interestingly they had a very
wide age range in their sample from 13 to 82 years
with only eight patients in the 20–40 year age
range and each participant was required to have
four X-rays of the knee. With the exception of
gender19 the main focus of most previous studies
of PFP has been on biomechanical rather than non-
biomechanical factors.20 Selhorst et al17 highlight
the necessity of addressing psychosocial factors in
PFP and there is some evidence to suggest a rela-
tionship exists between patients with PFP and
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activity levels,8 weight6 and pain mechanisms,21 these factors
may be of relevance to subgrouping approaches in the manage-
ment of patients suffering from PFP.
The present study is part of a larger programme of work
exploring whether targeted management of PFP subgroups can
optimise patient outcome. Previously, seven clinical assessment
tests have been proposed that may be useful in identifying clin-
ical subgroups.22 Further detail on these clinical assessment tests
and à priori test thresholds can be found in the protocol for this
study.22
In the present paper, we aimed to explore whether subgroup-
ing of patellofemoral pain patients, using a series of low cost
simple clinical tests, was possible. Four objectives were
identiﬁed:
1. To determine the relative frequency with which the patients
fell into each of the potential subgroups deﬁned by the à
priori test thresholds;
2. To assess whether the potential subgroups deﬁned by the à
priori test thresholds were mutually exclusive or whether,
and how frequently, patients fell into two or more
subgroups;
3. To ascertain whether other approaches such as hierarchical
clustering and latent proﬁle analysis, offered additional
insights into subgrouping of patients with PFP using data
from the same clinical assessment tests;
4. To report differences in patient-related characteristics (demo-
graphic, clinical and psychosocial) across subgroups.
METHODS
Design of the clinical study
A cross-sectional observational study design was used.
Participants attended an assessment clinic on one occasion prior
to physiotherapy treatment, at which a physiotherapist under-
took the seven clinical assessment tests (table 1). In addition, an
assessment of demographic (eg, age, gender and anthropom-
etry), clinical (eg, skin temperature index, time since onset), and
psychosocial characteristics (eg, physical activity, function,
quality of life and pain levels) was completed (table 2). No
formal power calculation was undertaken given the exploratory
nature of the study but a target sample of 150 was considered
sufﬁcient to estimate the proportion of participants who fell
into different subgroups and for multiple group membership,
with adequate precision.22
The setting and type of participants
Four National Health Service (NHS) physiotherapy clinics,
serving the general population, participated in this study; one in
primary care, three in hospital settings. Between May 2012 and
November 2013, patients aged between 18 and 40 years diag-
nosed with non-speciﬁc unilateral or bilateral PFP were
approached to participate in this study (ﬁgure 1). Eligibility
criteria were based on criteria used in two previous studies23 24
where patients with speciﬁc pathologies such as ligamentous
instability or patella subluxation were excluded, these are fully
detailed in the protocol for this study.22 Patients were included
in this study if the duration of their pain was at least 3 months
and they self-reported anterior or retropatellar pain on at least
two of the following activities: prolonged sitting, ascending or
descending stairs, squatting, running, kneeling and hopping/
jumping. Two of the following on clinical examination were also
required: pain during resisted isometric quadriceps contraction,
pain on palpation of the posterior facets of the patella, pain
during squatting. When eligible patients agreed to participate,
written informed consent was obtained.
Clinical assessment
There were seven clinical assessment tests (1) passive prone knee
ﬂexion (rectus femoris length), (2) passive knee extension in
supine (hamstrings length), (3) calf ﬂexibility standing method
(gastrocnemius length) measured using inclinometry, (4) Hip
abductor strength, (5) quadriceps strength measured using hand-
held dynamometry, (6) Total patellar mobility (medial plus
lateral glide) measured using the patellar glide test and (7) foot
pronation assessed by the Foot Posture Index (FPI). In the pres-
ence of bilateral PFP pain, assessment was undertaken on the
most affected leg, as nominated by the patient. To ensure stand-
ardisation across the study centres, all therapists attended an
initial, and three refresher, training days and were provided with
a manual outlining the assessment procedures. Each site was
visited by members of the research team ( JS and JJ) on at least
three occasions to monitor ﬁdelity with assessment procedures.
Statistical methods
For each measure of muscle ﬂexibility, the mean of three assess-
ments, reported in degrees from the baseline position, was taken
as the test score. For both measures of muscle strength, the
maximum moment measured in Newton-metre (Nm) from
three trials was taken as the test score. This was also normalised
to body mass that is Newton-metre per kilogram (Nm/kg). For
patellar mobility the total medial/lateral displacement in milli-
metres of the distal pole was taken as the test score. For the
seven clinical assessment tests, and patient demographic, clinical,
psychosocial and functional characteristics, summaries are pre-
sented using mean (SD), median (IQR) or frequency (%), as
appropriate.
In this paper we report the ﬁndings of an exploratory analysis
of the membership of predetermined subgroups using two
approaches. First the data were explored using à priori test
thresholds, based on 1 SD from published norms (table 3). The
lower limb biarticular muscle tightness subgroup was deﬁned by
lack of ﬂexibility in two of the three clinical assessment tests. For
quadriceps and hip abductor muscle weakness subgroups, the test
Table 1 Mean (SD) for the 7 clinical tests for 127 participants
Clinical assessment tests Rectus Femoris Length test° 129.4 (20.05)
Hamstring Length test° 151.4 (14.77)
Gastrocnemius Length test° 27.8 (10.75)
Maximum Quadriceps Strength Nm 73.7 (41.13)
Maximum Quadriceps Strength normalised to body mass Nm/kg 1.0 (0.51)
Maximum Hip Abductor Strength Nm 72.8 (38.85)
Maximum Hip Abductor Strength normalised to body weight Nm/kg 1.0 (0.50)
Total Patellar Mobility mm 12.2 (4.63)
Foot Posture index 4.4 (4.44)
The ‘°’ is the symbol for joint angles measured in degrees.
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Table 2 Patient-related (demographic, clinical and psychosocial) characteristics for 127 participants
Demographic characteristics Mean (SD) age in years 26 (5.7)
Number (%) of females 84 (66)
Mean (SD) height in m 1.7 (0.11)
Mean (SD) body mass in kg 73.5 (18.3)
Mean (SD) body mass index in kg/m2 25.4 (5.83)
Clinical characteristics Median (IQR) time since clinical onset in months* 24 (7–60)
Number (%) with bilateral pain 67 (52.8)
Number (%) with traumatic onset† 17 (13.4)
Mean (SD) patellar temperature index (celsius)‡§ 4.7 (3.55)
Psychosocial characteristics Mean (SD) Numerical Pain Rating Scale§ 4.7 (1.95)
Mean (SD) Self-completed Leeds Assessment of Neuropathic Symptoms and Signs pain scale (SLANSS)* 6.5 (5.84)
Mean (SD) Short-form McGill Pain Questionnaire
▸ Continuous pain 3.1 (1.95)
▸ Intermittent pain 2.4 (2.02)
▸ Neuropathic pain 0.8 (1.15)
▸ Affective descriptors 1.2 (1.76)
Number (%) with low physical activity level—(IPAQ)¶ 19 (15.0)
Mean (SD) Modified Functional Index Questionnaire§ 34.1 (16.97)
Mean (SD) Hopkins Symptom Checklist 1.3 (0.42)
Mean (SD) EQ-5D-5L
▸ Index value§ 0.7 (0.17)
▸ Visual Analogue Scale (VAS) 75.4 (16.56)
Mean (SD) WHO Disability Assessment Scale II* 19.4 (7.04)
Mean (SD) Movement Specific Reinvestment Scale
▸ Movement self-consciousness subscale 13.3 (6.69)
▸ Conscious motor processing subscale 17.4 (5.75)
*Three missing values.
†Two missing values.
‡Difference in skin temperature between the patella and anterior tibialis.
§One missing value.
¶Six missing values.
Figure 1 Participant ﬂow chart.
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score was in Nm because of the lack of available population data
normalised for weight. Percentages of participants falling into
individual subgroups and into multiple subgroups were estimated,
with 95% CIs calculated using exact binomial methods.
Sensitivity analysis was undertaken using different SDs from the
published population norms (1.5 SD, 2.0 SD and 2.5 SD).
Second the data were explored using two other approaches;
hierarchical agglomerative cluster analysis (using SPSS) and
latent proﬁle analysis (using Latent Gold). Hierarchical agglom-
erative cluster analysis, a bottom-up approach to partitioning
participants into subgroups based on the similarity (or distance)
of the set of variables (eg, clinical tests or measures), and latent
proﬁle analysis, a statistical method of estimating the probability
of individuals’ membership of latent (or unknown) classes (or
subgroups) based on a set of variables (eg, clinical tests or mea-
sures), in which it is assumed that the variables are independent,
given the class membership. For the hierarchical agglomerative
cluster analysis, Ward’s method was used, Euclidean distance
squared and standardised the data using the Z-scores. The
number of subgroups was based on the number which could be
supported within a clinical context.25
For latent proﬁle analysis, Akaike information criterion (AIC)
and Bayesian information criterion (BIC) were computed for
each model to aid the choice of model and hence the number of
subgroups.26 Both methods, hierarchical clustering and latent
proﬁle analysis were performed independently and parallel to
each other by two separate authors of this paper. In these ana-
lyses data were used from each ﬂexibility test separately and
strength normalised for body mass (Nm/kg). The mean and SD
of test scores are reported for each subgroup in each approach
and analysis of variance (ANOVA) was performed to test for sig-
niﬁcant differences in individual test scores between the groups.
The differences between means of other patient characteristics
were also explored using ANOVA. In both sets of ANOVAs,
when overall differences were statistically signiﬁcant (p<0.05),
multiple comparisons between subgroups were performed using
Tukey’s B (Wholly Signiﬁcant Difference) test;27 if observed sub-
group variances differed substantially, the sensitivity to the equal
variances assumption was assessed by also performing the
Games-Howell test.28 Comparisons between subgroups for
gender and activity were made using χ2-tests, with pairwise mul-
tiple comparisons using Bonferroni correction of p values when
overall differences were statistically signiﬁcant (p<0.05).
Approvals, consent and licenses
The study received ethical approval from NRES Committee
North West—Greater Manchester North, REC reference: 11/
NW/0814 and University of Central Lancashire (UCLan) Built,
Sport and Health (BuSH) Ethics Committee Reference Number:
BuSH 025. R&D approval was also obtained from each partici-
pating NHS trust and licenses for the questionnaire instruments
obtained, where required.
RESULTS
One hundred and thirty participants were recruited, three parti-
cipants did not have a complete set of seven clinical test scores
and were removed from further analyses (table 1). The study
cohort was predominantly female and on average was slightly
overweight, the mean age was 26 years (SD 5.7; table 2).
No participant met the à priori criteria for hypermobility, few
for lower limb biarticular muscle tightness (27.6%, 95% CI
20.0% to 36.2%) or foot pronation (33.9%, 95% CI 25.7% to
42.8%) but most met the criteria for quadriceps weakness
(98.4%, 95% CI 94.4% to 99.8%), patellar hypomobility
(96.1%, 95% CI 91.1% to 98.7%) and hip abductor weakness
(88.2%, 95% CI 81.3% to 93.2%). Consequently, most partici-
pants (89.8%, 95% CI 83.1% to 94.4%) met the criteria for at
least three subgroups: 40.2% fell into three subgroups; 44.1%
Table 3 Distribution of 127 participants into predetermined subgroups using different SD from population norms
Published population norm
SD from published population norm
1 SD 1.5 SD 2 SD 2.5 SD
Mean (SD) n (%) n (%) n (%) n (%)
Lower limb biarticular tightness 35 (27.6) 12 (9.4) 8 (6.3) 3 (2.4)
Quadriceps 132.21 (16.39) 33 (30) 19 (15.5) 12 (9.4) 3 (2.4)
Hamstrings Male:
142.55 (6.85)
Female:
153.66 (11.13)
31 (24.4) 18 (14.2) 9 (7.1) 4 (3.1)
Gastrocnemius 35.22 (6.59) 74 (58.3) 46 (36.2) 38 (29.1) 24 (18.9)
Hip abductor weakness Male:
Age <30: 185 (37.6)
Age ≥30: 163 (37.4)
Female:
Age <30: 114 (31.8)
Age ≥30: 102 (26.0)
112 (88.2) 100 (78.7) 66 (52) 38 (29.9)
Quadriceps weakness Male:
Age <30: 242 (55.8)
Age ≥30: 236 (43.8)
Female:
Age <30: 160 (26.4)
Age ≥30: 157 (41.9)
125 (98.4) 119 (93.7) 115 (90.6) 104 (81.9)
Patellar hypomobility 26.2 (5.8) 122 (96.1) 111 (87.4) 89 (70.1) 63 (49.6)
Patellar hypermobility 26.2 (5.8) 0 0 0 0
Foot pronation 4 (3) 43 (33.9) 18 (14.2) 17 (13.4) 3 (2.4)
No subgroup 0 1 (0.8) 2 (1.6) 7 (5.5)
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into four subgroups and 5.5% into ﬁve subgroups (ﬁgure 2).
Even when the most extreme values of 2.5 SD was considered,
only 38.6% (n=49) fell into just one subgroup.
Preliminary analysis of both hierarchical cluster and latent
proﬁle analysis, showed a similar mean hamstring length across
subgroups, therefore this variable was excluded from the ﬁnal
analyses for both approaches. For the latent proﬁle analysis
approach, the AIC and BIC suggested either a three or ﬁve
cluster solution as the best ﬁt to the data. Three subgroups were
chosen, as this would be more feasible to implement in practice
and partitioning into ﬁve subgroups did not offer any further
insight into potential treatment regimens.
Both classiﬁcation methods, hierarchical clustering and latent
proﬁle analysis, generated subgroups which, on interpretation of
the mean test scores across the six clinical assessments, could be
given the same nomenclature (table 4): there was a ‘strong’ sub-
group, a ‘weak and tighter’ subgroup, and a ‘weak and pronated
foot’ subgroup. In both methods, the ‘strong’ subgroup exhib-
ited the highest mean quadriceps and hip abductor strength
with the most ﬂexible rectus femoris and subgroup membership
was highly consistent. The ‘weak and tighter’ subgroup, exhib-
ited weak mean quadriceps and hip abductor strength and were
less ﬂexible (in one of the two assessments). The ‘weak and pro-
nated foot’ subgroup exhibited the highest mean FPI, and in the
hierarchical clustering method, this was also accompanied by
the greatest patellar mobility. However, only about half of the
participants were consistently classiﬁed across the hierarchical
cluster and latent proﬁle analysis methods for these two sub-
groups (table 5).
Table 6 shows the comparison of other patient-related
factors across the three subgroups generated by each of the
methods. The ‘strong’ subgroup had more males, lower body
mass index (BMI) and higher levels of physical activity; they
also exhibited lower pain scores with signiﬁcantly lower
SLANSS; function as measured by the MFIQ was signiﬁcantly
better than the ‘weak and tight’ subgroup when classiﬁed by
the latent proﬁle analysis, and there was a trend towards
better quality of life compared to the other subgroups. The
‘weak and tighter’ subgroup had signiﬁcantly higher BMI and
worse MFIQ scores when classiﬁed by the latent proﬁle ana-
lysis, and there was a trend towards low physical activity and
longer duration of PFP, when classiﬁed by the hierarchical
cluster analysis. The ‘weak and pronated foot’ subgroup was
signiﬁcantly younger at time of ﬁrst assessment and had the
shortest duration since the onset of their PFP according to
both classiﬁcation methods.
Figure 2 Subgrouping of participants based on cut-offs 1 SD from
population-based mean*. *Based on 125 participants with quadriceps
weakness; in addition there were 2 participants without quadriceps
weakness (1 hypomobility of patella only, 1 hypomobility of patella and
foot pronation).
Table 4 Mean test scores across the three subgroups generated by hierarchical cluster and latent profile analysis
Subgroup
WEAK and TIGHTER
Mean (SD)
STRONG
Mean (SD)
WEAK and PRONATED FOOT
Mean (SD) ANOVA
Hierarchical clustering N=49 N=29 N=49
Rectus Femoris Length0 121.8 (19.48) 140.7 (17.06)* 130.4 (19.21) F=9.26, p<0.001
Gastrocnemius Length0 22.3 (9.71)† 28.0 (6.51)† 33.1 (11.21)† F=14.98, p<0.001
Quadriceps Strength
Nm/kg
0.84 (0.32) 1.65 (0.53)* 0.82 (0.32) F=53.01, p<0.001
Abductor Strength
Nm/kg
0.79 (0.30) 1.69 (0.46)* 0.83 (0.29) F=75.11, p<0.001
Total Patellar Mobility mm 10.0 (3.55) 10.8 (3.03) 15.4 (4.61)* F=27.12, p<0.001
Foot Posture index 3.3 (4.16) 3.0 (5.28) 6.3 (3.49)* F=8.22, p<0.001
Latent profile analysis N=50 N=28 N=49
Rectus Femoris Length0 119.1 (18.06)* 140.6 (16.91) 133.5 (18.99) F=14.58, p<0.001
Gastrocnemius Length0 28.7 (11.08) 28.2 (6.29) 26.6 (12.39) F=0.53, p=0.59
Quadriceps Strength
Nm/kg
0.62 (0.24)† 1.68 (0.52)† 1.04 (0.23)† F=97.54, p<0.001
Abductor Strength
Nm/kg
0.60 (0.18)† 1.73 (0.42)† 1.02 (0.21)† F=167.69, p<0.001
Total Patellar Mobility mm 12.5 (3.77 10.5 (3.15) 12.8 (5.84) F=2.55, p=0.083
Foot Posture index 2.80 (4.35) 3.71 (5.33) 6.37 (3.11)* F=9.51, p<0.001
†All groups significantly different from each other (p<0.05).
*Group significantly different from each of the other two (p<0.05).
ANOVA, analysis of variance.
Selfe J, et al. Br J Sports Med 2016;50:873–880. doi:10.1136/bjsports-2015-094792 5 of 9
Original article
DISCUSSION
The present ﬁndings suggest that three subgroups of patients
with PFP may be identiﬁed using six low cost, simple clinical
assessment, tests that can be applied in routine practice. This
study provides an important ﬁrst step in deducing whether tar-
geted intervention for patients with PFP may be a useful strategy
that ultimately leads to improved outcomes for patients.
Previous work on subgrouping has mostly focused on using
imaging techniques13–16 rather than on clinical testing; the small
number of studies which have had a greater clinical focus have
been small scale with a total of just 71 patients across two
studies17 18 these may be underpowered to detect subgroups.
Although it was anticipated that separate subgroups would be
identiﬁed by each of the clinical assessment tests, this was not
the case. In part, this may be because of inadequately deﬁned á
priori diagnostic thresholds available in the literature, but even
applying more extreme thresholds suggested most participants
fell into more than one predetermined subgroup (table 3).
Multiple predetermined subgroup membership was conﬁrmed
by hierarchical cluster and latent proﬁle analysis, which gener-
ated three novel subgroups based on a combination of test
scores. A ‘strong’ subgroup had the highest hip abductor and
quadriceps strength mean scores and greatest rectus femoris
length, while a ‘weak and tighter’ group had low mean scores
for hip abductor and quadriceps strength and evidence of less
ﬂexibility, although the ‘weak and pronated foot’ subgroup
appeared to be reliant on the results of just the FPI in the latent
proﬁle analysis, greater patellar mobility additionally appeared
to be an important factor in the hierarchical cluster analysis
(table 4). Using different populations to that reported in this
paper previous researchers17 18 have proposed four rather than
three clinical subgroups of patients with PFP. However, in
common with the results reported here both previous papers
describe a tight or hypomobile group that included
Table 5 Comparison of subgroup membership between the two classification methods
Subgroups generated by Latent profile analysis Total
Hierarchical cluster analysis ‘Weak and tight’ ‘Strong’ ‘Weak and pronated foot’
‘Weak and tighter’ 25 1 23 49
‘Strong’ 1 26 2 29
‘Weak and pronated foot’ 24 1 24 49
Total 50 28 49 127
Table 6 Patient-related factors distributed across the three subgroups generated by the hierarchical cluster and latent profile analysis
Subgroup
WEAK and TIGHTER
Mean (SD)
STRONG
Mean (SD)
WEAK and PRONATED FOOT
Mean (SD)
Test statistic
and p value
Hierarchical cluster analysis N=49 N=29 N=49
Age 26.9 (5.34) 28.3 (6.15)* 24.9 (5.36)* F=3.85, p=0.024
Gender (% male) 13 (26.5%) 17 (53.6%)† 13 (26.5%) χ2=10.29, p=0.006
BMI 25.8 (5.37) 23.5 (4.44) 26.2 (6.77) F=2.12, p=0.12
Physical activity level (low) 10 (20.8%) 2 (6.9%) 7 (15.2%) χ2=2.69, p=0.26
Movement specific reinvestment scale 31.4 (11.33) 29.0 (12.50) 30.9 (10.66) F=0.418, p=0.66
Time from onset 58.0 (63.77) 45.2 (57.5) 34.1 (43.15) F=2.22, p=0.11
HSCL (depression) 1.3 (0.38) 1.3 (0.57) 1.3 (0.36) F=0.066, p=0.94
Pain (NPRS) 5.2 (1.88) 4.1 (1.68) 4.5 (2.08) F=2.84, p=0.062
SLANSS (total) 8.1 (5.85)* 4.4 (5.58)* 6.1 (5.62) F=3.98, p=0.021
EQ-5D-5 L VAS 75.9 (14.40) 77.9 (17.23) 73.5 (18.22) F=0.67, p=0.52
WHO Disability Assessment Scale II 20.9 (7.27) 17.5 (8.27) 19.2 (5.70) F=2.24, p=0.11
Modified Functional Index Questionnaire 37.0 (16.99) 28.0 (15.45) 35.0 (17.21) F=2.72, p=0.070
Latent profile analysis N=50 N=28 N=49
Age 27.1 (5.56) 28.1 (5.99)* 24.8 (5.26)* F=3.74, p=0.026
Gender (% male) 8 (16.0%)* 17 (60.7%)* 18 (36.7%) χ2=16.32, p<0.001
BMI 28.3 (6.81)† 23.2 (4.60) 23.7 (3.89) F=12.24, p<0.001
Physical activity level (low) 8 (16.7%) 2 (7.1%) 9 (19.1%) χ2=2.03, p=0.36
Movement specific reinvestment scale 30.6 (10.89) 28.6 (12.34) 31.9 (11.18) F=0.77, p=0.47
Time from onset 46.7 (54.67) 47.2 (57.70) 44.5 (56.93) F=0.03, p=0.97
HSCL (depression) 1.3 (0.37) 1.23 (0.45) 1.3 (0.46) F=0.21, p=0.81
Pain (NPRS) 5.0 (2.03) 4.14 (1.76) 4.6 (1.93) F=1.96, p=0.15
SLANSS (total) 6.5 (5.36) 4.14 (5.62)* 7.8 (6.11)* F=3.56, p=0.031
EQ-5D-5 L VAS 72.3 (18.54) 80.4 (15.61) 75.8 (14.40) F=2.18, p=0.12
WHO Disability Assessment Scale II 20.4 (6.59) 16.8 (8.05) 20.0 (6.60) F=2.59, p=0.079
Modified Functional Index Questionnaire 38.1 (16.98)* 28.3 (16.52)* 33.5 (16.46) F=3.18, p=0.045
*Subgroup pairs different (p<0.05).
†Different from each of the other two subgroups (p<0.05).
BMI, body mass index; HSCL, Hopkins Symptom Checklist; NPRS, Numerical Pain Rating Scale; SLANSS, Self-completed Leeds Assessment of Neuropathic Symptoms and Signs pain
scale; VAS, visual analogue scale.
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measurements of rectus femoris and gastrocnemius length. Both
previous papers also describe a weak group where weakness in
the quadriceps and hip muscles were identiﬁed by a combination
of visual inspection and functional testing rather than through
speciﬁc objective testing using dynamometry. It is interesting to
note that three independent studies performed in different
countries USA,17 Australia18 and the UK, each with a slightly
different PFP population and each using slightly different
methods have reported some consistency in subgroups of
patients with PFP.
Therapist ﬁdelity to the assessment process was high with
only three patients with incomplete clinical assessments. This
suggests that the assessments were feasible in practice within
both primary and tertiary care physiotherapy clinics.
Exploratory analyses also suggested that clinical assessment test
scores of hamstring length are not informative in terms of sub-
grouping. From a clinical perspective these results are very inter-
esting as hamstring stretching is often a component of
physiotherapy treatment regimens for PFP. While hamstring
tightness does not appear to be an important factor for sub-
grouping in PFP, our results compared to normative data found
tight hamstrings in 24.4% (n=31) participants indicating that
some patients may beneﬁt from treatment. The research thera-
pists conducting the tests found the assessment of quadriceps
strength easier than the hip abductor measurement and we test
scores were moderately highly correlated (r=0.72), so further
investigation of the ‘added value’ of performing both tests is
merited. Further work to identify the optimal thresholds for
individual and combined clinical assessment tests which best
classify PFP participants into the three novel subgroups is cur-
rently being undertaken. This work could potentially reduce the
burden of assessment by reducing the number of tests required.
Other measures were included to assess patient characteristics
such as the Hopkins Symptom Checklist and the Movement
Speciﬁc Reinvestment Scale. However, these tests did not seem
to contribute signiﬁcantly to our understanding of subgroups or
were difﬁcult to administer, for example, the Short-form McGill
Pain Questionnaire, so we propose to exclude these tests in
future studies of subgrouping patients with PFP. WHODAS II
scores were moderately highly correlated (Spearman’s r=−0.68)
with the EQ-5D-5 L, which has become ﬁrmly established as the
‘gold standard’ quality-of-life outcome measure for musculoskel-
etal physiotherapy practice in the UK,29 so on this basis we
would also exclude the WHODAS II from further studies.
The baseline characteristics of the participants suggest that
the study population was representative of patients with PFP
attending physiotherapy clinics.23 30 31 The ratio of females to
males was 2 to 1, a high proportion had bilateral pain (53%),
and only a small percentage (13.8%) of patients reported a trau-
matic onset of pain. While the BMI proﬁle of this cohort might
be higher than expected for athletes with PFP, it was still lower
than that of the UK general population and reﬂects that this was
a general clinical population.32 Mean clinical assessment test
scores were also consistent with published ﬁndings for PFP
patients.33–35 Across the whole sample, pain scores were rela-
tively low, and function scores, levels of physical activity and
quality-of-life scores were relatively good, as might be expected
for what is considered a relatively low grade bothersome muscu-
loskeletal condition. There were marked differences in the rela-
tive frequency of men and women across the subgroups.
Although overall there were about twice as many women as
men in the study population, there were relatively more men in
the ‘strong’ group. While this observation might be considered
inevitable because females tend to have lower muscle strength
than males, about half or 4 in 10 were women in this subgroup,
dependent on the method used (table 6). Analysis suggested that
subgroups were stable for female participants but the number of
males were too small for further analysis (data not shown).
Further research should focus on potential differences in
characteristics between subgroups and on investigating whether
there are differences in subgroups between genders.
There were also differences between the subgroups with
respect to some of the other participant characteristics. While it
is not possible from this cross-sectional study to identify the dir-
ection of the relationship between the test scores and these
other characteristics, they may provide further insights into aeti-
ology or sequelae, which could guide further research on pre-
ventative strategies or therapeutic management. The ‘weak and
tighter’ subgroup, generated by latent class analysis, had signiﬁ-
cantly higher mean BMI, with the majority being overweight
and lowest physical activity, when subgroups were generated by
the hierarchical approach. Being overweight has been associated
with patellar cartilage loss.36 37 The speculated relationship
between patellofemoral pain and patellofemoral osteoarthritis
and the known relationship between obesity and knee osteoarth-
ritis suggests that this observation is worthy of further investiga-
tion.6 Whether the development of patellofemoral OA is
potentially greater in this group compared to other two groups
is at this stage highly speculative. In the short term it might
however, point towards the need for adjunct strategies to
promote activity and encourage weight loss in this subgroup, in
addition to strengthening and ﬂexibility exercises. While lower
limb muscle weakness in patients with PFP is well known, it was
more surprising that a ‘strong’ subgroup existed with a trend
towards less pain, higher function and better quality of life.
This might suggest that the other well-known observation in
patients with PFP, that of poor neuromuscular control, is
important and interventions focusing on movement control are
required.38 39 The signiﬁcantly younger age of the ‘weak and
pronated foot’ group is interesting but initial suggestions of a
developmental issue, are tempered by us speciﬁcally recruiting
over 18-year-olds to minimise the chance of ‘growth spurt’ pro-
blems. Other studies have demonstrated higher levels of passive
ankle dorsiﬂexion in adolescents with knee pain40 and this
might suggest strategies including foot orthoses are warranted
speciﬁcally for this subgroup.
Limitations
This was not an efﬁcacy trial and there are no outcome data fol-
lowing treatment. Therefore, it is unclear whether using the
three subgroups suggested by this study will have any impact on
modifying clinical practice or more importantly on improving
patient outcomes. We considered that we needed at least 150
participants but recruited 130 of which 127 had sufﬁcient data
to be included in the exploratory analyses. Recruitment had to
close because of time constraints. Although the target sample
size was not reached, CIs for subgroups based on a priori
thresholds are relatively precise and similar subgroups across
hierarchical cluster and latent proﬁle analysis have been gener-
ated. However, given the small number of men in the sample,
we could not conﬁrm that subgroupings are similar in different
genders. Additionally the study focused speciﬁcally on the
young adult population aged 18–40 years, so it is unknown if
these subgroups are relevant to adolescents or older patients.
There are a myriad of different approaches for subgrouping
data and these will tend to give different results for the same
data set.25 We chose to explore the data using two different
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approaches to provide some internal validation. We were to
some extent reassured that generated subgroups could be given
the same nomenclature. However, there were important differ-
ences in participant characteristics and the mean test scores
between the groups. This makes clinical interpretation difﬁcult.
The two approaches differ in how they generate subgroups with
latent proﬁle analysis splitting the sample into smaller groups
whereas hierarchical agglomerative clustering has a bottom-up
approach. Also, latent proﬁle analysis differs from cluster ana-
lysis methods in that individuals are not assigned deﬁnitively to
classes based on a chosen distance measure but are typically
assigned to classes based on probabilities of membership of each
class, usually estimated via maximum-likelihood estimation of
the parameters of a speciﬁed model. Unlike cluster analysis,
there is no requirement to explicitly scale each variable as the
classiﬁcation is based directly on the distributional properties of
the variables and classiﬁcations are therefore unaffected by the
choice of a variable’s scale. Owing to these features, latent
proﬁle analysis is increasingly considered a better analytical
approach to hierarchical clustering methods.40 It also provides
information on the most likely number of clusters (by using the
AIC and BIC), whereas this is more difﬁcult to assess in hier-
archical clustering methods. However, hierarchical clustering
may more closely reﬂect clinical decision-making where test
scores are assessed sequentially to build up a picture of the main
problem of the patient. Further validation of the subgroups
using other data sets is required which would also provide
further information on the relevance of patellar mobility and
other patient characteristics. Furthermore, it will be important
to determine if optimising treatments based on subgroups will
improve patient outcomes.
SUMMARY AND CONCLUSIONS
Three subgroups of patients with PFP have emerged based on
six clinical assessment tests. A ‘strong’ subgroup had the great-
est rectus femoris length, lowest pain scores, signiﬁcantly
more males, better function and better quality-of-life and
were the oldest. A ‘weak and tighter’ subgroup had signiﬁ-
cantly higher BMI, MFIQ and SLANSS with a trend towards
lower physical activity levels and the longest duration of PFP.
A ‘weak and pronated foot’ subgroup had the greatest patellar
mobility, was signiﬁcantly younger at time of ﬁrst assessment
and had the shortest duration of PFP. The study suggests that
the six assessment procedures are feasible for therapists in
primary care and hospital settings to perform in routine prac-
tice. We propose to undertake further work to validate these
subgroups using external data sets, to examine optimal
thresholds to assign participants to groups and, to assess
whether more targeted intervention, based on these sub-
groups, would improve patient compliance and outcome, and
as a result be more cost-effective.
What are the ﬁndings?
▸ Three subgroups of patellofemoral patients have been
identiﬁed.
▸ The subgroups are: ‘strong’; ‘weak and tighter’; ‘weak and
pronated’.
▸ Six simple low cost clinical tests can be used to identify the
subgroups.
How might it impact on clinical practice in the future?
Targeted intervention based on these subgroups may improve
patient outcomes.
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